A Phase 2b/3, Randomized, Observer-Blinded, Placebo-Controlled, Multicenter Clinical Study Evaluating the Efficacy and Safety of Investigational SARS-CoV-2 mRNA Vaccine CVnCoV in Adults 18 Years of Age and Older

Clinical trial NCT04652102 · COMPLETED

Trial details

NCT number: NCT04652102
Sponsor: CureVac
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Covid19 SARS-CoV-2

Start date: 2020-12-11
Primary completion: 2022-06-10
Enrollment: 39680

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.